[go: up one dir, main page]

BR0313665A - Utilização de bupropion para o tratamento da sìndrome das pernas inquietas - Google Patents

Utilização de bupropion para o tratamento da sìndrome das pernas inquietas

Info

Publication number
BR0313665A
BR0313665A BR0313665-5A BR0313665A BR0313665A BR 0313665 A BR0313665 A BR 0313665A BR 0313665 A BR0313665 A BR 0313665A BR 0313665 A BR0313665 A BR 0313665A
Authority
BR
Brazil
Prior art keywords
bupropion
treatment
restless leg
leg syndrome
syndrome
Prior art date
Application number
BR0313665-5A
Other languages
English (en)
Inventor
David Wayne Robertson
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of BR0313665A publication Critical patent/BR0313665A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Structure Of Belt Conveyors (AREA)

Abstract

"UTILIZAçãO DE BUPROPION PARA O TRATAMENTO DA SìNDROME DAS PERNAS INQUIETAS". A presente invenção fornece a utilização de bupropion ou um sal farmaceuticamente aceitável deste no tratamento da síndrome de pernas inquietas em seres humanos.
BR0313665-5A 2002-08-26 2003-08-22 Utilização de bupropion para o tratamento da sìndrome das pernas inquietas BR0313665A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40594302P 2002-08-26 2002-08-26
PCT/US2003/024795 WO2004017951A1 (en) 2002-08-26 2003-08-22 Use of bupropion for the manufacture of a medicament for treating restless legs syndrome

Publications (1)

Publication Number Publication Date
BR0313665A true BR0313665A (pt) 2005-06-14

Family

ID=31946948

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0313665-5A BR0313665A (pt) 2002-08-26 2003-08-22 Utilização de bupropion para o tratamento da sìndrome das pernas inquietas

Country Status (8)

Country Link
US (1) US20040115263A1 (pt)
EP (1) EP1545486A1 (pt)
JP (1) JP2005538147A (pt)
AU (1) AU2003261459A1 (pt)
BR (1) BR0313665A (pt)
CA (1) CA2494658A1 (pt)
MX (1) MXPA05001557A (pt)
WO (1) WO2004017951A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1575565B1 (en) * 2003-08-08 2010-01-06 Biovail Laboratories International Srl Modified-release tablet of bupropion hydrochloride
US7241805B2 (en) 2005-06-27 2007-07-10 Biovail Laboratories, Inc. Modified release formulations of a bupropion salt
CN101641090B (zh) * 2006-12-19 2012-12-05 亚勒斯有限公司 莫达非尼在制备治疗多动腿综合征的药物中的应用
CN102762201B (zh) 2009-11-06 2013-12-18 爱思开生物制药株式会社 注意力缺陷/多动症的治疗方法
EP2496227B1 (en) 2009-11-06 2019-05-22 SK Biopharmaceuticals Co., Ltd. Methods for treating fibromyalgia syndrome
US8623913B2 (en) * 2010-06-30 2014-01-07 Sk Biopharmaceuticals Co., Ltd. Methods for treating restless legs syndrome
US9610274B2 (en) 2010-06-30 2017-04-04 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
WO2014043103A1 (en) 2012-09-11 2014-03-20 Coherus Biosciences, Inc. Correctly folded etanercept in high purity and excellent yield

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04002709A (es) * 2001-09-24 2005-06-06 Johnson & Johnson Derivados articonvulsivos utiles para el tratamiento del sindrome de extremidades inquietas y trastorno periodico del movimiento de extremidades.

Also Published As

Publication number Publication date
US20040115263A1 (en) 2004-06-17
WO2004017951A1 (en) 2004-03-04
MXPA05001557A (es) 2005-08-19
EP1545486A1 (en) 2005-06-29
JP2005538147A (ja) 2005-12-15
AU2003261459A1 (en) 2004-03-11
CA2494658A1 (en) 2004-03-04

Similar Documents

Publication Publication Date Title
CY1121408T1 (el) Προληψη και θεραπεια συνουκλεϊνοπαθειας και αμυλοειδοπαθειας
BRPI0407662A (pt) derivados do ácido 1-fenilalcanocarboxìlico para o tratamento de doenças neurodegenerativas
EP1499277A4 (en) MODIFICATION OF FOOD BEHAVIOR
PT1605956E (pt) Administração de capsaicinóides para o tratamento da osteoartrite
EE02971B1 (et) Droloksüfeeni või selle soolade kasutamine luuhaiguste vastase ravimi valmistamiseks
LTC1425001I2 (lt) Fenetanolamino dariniai, skirti kvėpavimo ligoms gydyti
PT1313489E (pt) Composicoes farmaceuticas para o tratamento de mucosite, estomatite e sindroma de behcet
BR0309099A (pt) Composições farmacêuticas com base em anticolonérgicos e inibidores da p38 cinase
DK1525177T3 (da) Substituerede 1,3-diphenylprop-2-en-1-on-derivater, fremstilling og anvendelse deraf
DOP2002000429A (es) Imidazotriazinas
PT1202722E (pt) Usos para o tratamento ou prevencao de disturbios do sono usando doses muito baixas de ciclobenzaprina
MXPA05003253A (es) Nuevos derivados de pirimidinamida y el uso de los mismos.
PT1228028E (pt) Sais de hidroxieicosatetraeniato, composicoes e metodos para utilizacao no tratamento de perturbacoes da secura ocular
DE50101034D1 (de) Medizinischer oder dentalmedizinischer behandlungsstuhl
BR0313665A (pt) Utilização de bupropion para o tratamento da sìndrome das pernas inquietas
CY1107312T1 (el) Θειικη 3,5,3’-τριιωδοθυρονινη σαν θυρεοειδο-μιμητικος παραγοντας και φαρμακευτικα σκευασματα της
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine
PT1362590E (pt) Utilizacao de cilobradina ou dos seus sais farmaceuticamente aceitaveis para o tratamento ou prevencao de falha cardiaca
EE200200605A (et) Asendatud akrüloüüldistamütsiini derivaadi kasutamine ravimi valmistamiseks, mis on ette nähtud glutatiooni kõrge tasemega seotud kasvajate raviks
ATE456943T1 (de) Knie-immobilisator
CY1109771T1 (el) Η χρηση της φορμοτερολης στην προφυλακτικη και/ή θεραπευτικη αντιμετωπιση της μυικης απωλειας και/ή του καχεκτικου συνδρομου τα οποια συνδεονται με τις καταβολικες συνθηκες ορισμενων παθησεων. οπως ο καρκινος, to aids, οι μολυνσεις, ο διαβητης και αλλες
BRPI0412288A (pt) uso de aivlosina para o tratamento, prevenção ou controle de doenças em virtude de brachyspira pilosicoli em porcos e ornithobacterium rhinotracheale em aves
PT1052991E (pt) Utilizacao de loperamida para o tratamento de infeccoes microbianas
BRPI0406746A (pt) Preparado de combinação contra tontura
DK1497250T3 (da) Hyperforinderivater, anvendelse heraf og sammensætninger indeholdende disse

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A,5A,6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2069 DE 31/08/2010.